Advancements in alternating electric fields can significantly improve the survival rates of patients with metastatic non-small cell lung cancer (mNSCLC) who have not responded to platinum-based chemotherapy. This study shows that combining alternating electric field therapy with standard-of-care treatments can lead to better outcomes compared to standard-of-care treatments alone.
- Clinical, Research Articles
A phase 3, open-label, randomized LUNAR study comparing Tumor Treating Fields therapy combined with standard systemic treatment versus standard systemic treatment alone in metastatic non-small-cell lung cancer patients who have experienced progression during or after platinum-based therapy.
- Source: https://www.sciencedirect.com/science/article/abs/pii/S1470204523003443?via%3Dihub
- Authors: Ticiana Leal MD, Prof Rupesh Kotecha MD, Rodryg Ramlau MD, Li Zhang MD, Prof Janusz Milanowski MD, Manuel Cobo MD, Jaromir Roubec MD, Lubos Petruzelka MD, Libor Havel MD, Sujith Kalmadi MD, Jeffrey Ward MD, Zoran Andric MD, Thierry Berghmans MD, Prof David E. Gerber MD, Goetz Kloecker MD, Prof Rajiv Panikkar MD, Joachim Aerts MD, Angelo Delmonte MD, Prof Miklos Pless MD, Prof Richard Greil MD, Prof Corey Langer MD.
Share the Post:
Related Posts
ECCT is what keeps me active and always enthusiastic about completing my daily routines